Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.8071
-0.0229 (-2.76%)
Jul 9, 2026, 4:00 PM EDT - Market closed
Invivyd Market Cap
Invivyd has a market cap or net worth of $237.78 million as of July 9, 2026. Its market cap has increased by 164.28% in one year.
Market Cap
237.78M
Enterprise Value
69.00M
1-Year Change
164.28%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $237.78M, a decrease of -89.51%. That is a compound annual growth rate of -36.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 237.78M | -65.26% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 259.67M |
| AC Immune | 248.99M |
| Fulcrum Therapeutics | 247.88M |
| Anavex Life Sciences | 246.51M |
| Orchestra BioMed Holdings | 244.31M |
| ProQR Therapeutics | 242.72M |
| Sol-Gel Technologies | 242.30M |
| Codexis | 241.78M |